TLR9 and metabolic dysfunction-associated steatohepatitis: It is noteworthy that the inhibition of TLR-9 expression in mouse models fed a high-fat diet has been demonstrated to result in a reduction in the NASH phenotype and a significant shift towards the M2 phenotype in KCs, accompanied by a notable control of M1 activation (Mridha et al., 2017a).